Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02841072 · ClinicalTrials.gov registry record

Chart Review Study of Medical Abortion

A clinical trial, sponsored by Gynuity Health Projects.

Completed
Registry status
579
Enrollment target

NCT02841072: Completed study, sponsored by Gynuity Health Projects.

NCT02841072 is a clinical trial that has completed, run by Gynuity Health Projects. The registered enrollment target is 579 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02841072 has completed, sponsored by Gynuity Health Projects.

COMPLETED
Registry status
579 participants
Enrollment target

Study Summary

The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal misoprostol at 64-70 days of gestation.

Primary Outcome

Defined as a complete abortion without use of surgery

Trial Details

FieldValue
Enrollment Target 579 participants
Start Date 2015-05
Est. Completion 2016-04
Gynuity Health Projects

29 total trials

What the finished NCT02841072 record still lists

NCT02841072 is an observational study that tracks outcomes without assigning an intervention. The registered 579 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02841072 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02841072 about?

NCT02841072 is a clinical study titled "Chart Review Study of Medical Abortion". The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal misoprostol at 64-70 days of gestation.

What is the current status of trial NCT02841072?

This trial is currently completed. The enrollment target is 579 participants. The study started on 2015-05. Estimated completion is 2016-04.

Who is sponsoring clinical trial NCT02841072?

This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04575935 · 580 participants · Phase 3

    Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

  • NCT05143177 · 580 participants · Phase 2

    A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

  • NCT05696353 · 580 participants · Phase 3

    Teen Driving Translation Study (NIH)

  • NCT06578104 · 580 participants

    PULSED AF Post-Approval Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02841072, the US trial registry maintained by the National Library of Medicine. NCT02841072 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.